
Thoracic Masterclass: All About Collaboration: Maximizing Outcome in Thoracic Surgery Part II | Recorded at the AATS 106th Annual Meeting
Examine the multidisciplinary strategies shaping modern thoracic oncology in this masterclass recorded at the AATS 106th Annual Meeting. Through expert presentations, debates, and panel discussions, faculty explore the collaborative management of thymic malignancies, complex post-induction resections involving major vascular structures, emerging bronchoscopic technologies for non-small cell lung cancer, and the role of extrathoracic pulmonary metastasectomy. Gain insights into evolving treatment paradigms and the critical decision-making processes that optimize outcomes for patients with complex thoracic cancers.
This session includes the following presentations:
- Medical Optimization and Induction of Resectable Thymic Disease
- Post Induction Thymic Resections for Arch and Great vessel involvement
- Panel Discussion
- Evolving Bronchscopic Technology for Diagnosis and Treatment Non-Small Cell Lung Cancer
- Extrathoracic SP Lung Resections for Non-Small Cell Lung Cancer: Benefits/Hazards
- Panel Discussion
- Debate: Resectability Should be Determined Prior to Induction | Pro
- Debate: Resectability Should be Determined Prior to Induction | Con
- Panel Discussion
The planners and faculty for this activity did not have any relevant relationships with ACCME defined ineligible companies to disclose, unless listed here/below. All relevant relationships were mitigated prior to the start of the activity according to The Standards for Integrity and Independence in Accredited Continuing Education.
Purpose (Desired Learning Outcome)
Following this activity, learners will strengthen multidisciplinary treatment planning for complex thoracic oncology cases, supporting more consistent approaches to resectability assessment and procedural strategy selection.
ACCME Accreditation Statement
The American Association for Thoracic Surgery is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The American Association for Thoracic Surgery designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Commercial Support
The American Association for Thoracic Surgery received commercial support from the following organizations:
- Abbott
- J&J Medtech Heart Recovery
- W.L. Gore & Associates
Available Credit
- 1.25 ABS Accredited CME
Successful completion of this CME activity, [which includes participation in the evaluation component], enables the learner to earn credit toward the CME [and Self-Assessment] requirement(s) of the American Board of Surgery Continuous Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit. - 1.25 ABTS Accredited CMESuccessful completion of this CME activity, [which includes participation in the evaluation component], enables the learner to earn credit toward the CME [and Self-Assessment / Patient Safety / Performance in Practice requirements] of the American Board of Thoracic Surgery’s Maintenance of Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABTS credit.
- 1.25 AMA PRA Category 1 Credit(s)™The American Association for Thoracic Surgery designates this Enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.25 Participation

Facebook
X
LinkedIn
Forward